Information Library

Results for: Business transformation - Lower portfolio & investment risks - Capital

In the complex environment of the New Health, Quintiles is committed to helping you succeed. At every stage of your product’s lifecycle, we are dedicated to delivering real results, being proactive in navigating issues and thinking of new solutions.  Search our library today.

Start Over

  • Sort by:
  • Recently Added
  • Title

  • UK Market Access Insight Brief

    White Paper — May 30, 2012
    Insight Briefing series on Market Access in key European countries

  • Partnering to Maximize Rewards in Pharmerging Markets

    White Paper — September 15, 2011
    In the past few years so-called “pharmerging” markets have been heralded as the hottest growth area for biopharmaceutical drugs. With large populations, growing disposable income and unmet medical needs, these markets have seen doubledigit growth rates in pharmaceutical spending.

  • Quintiles Supports Samsung's Entry into BioPharma Market through Joint Venture

    Press Release — February 28, 2011 – The Samsung Group, South Korea’s largest industrial group, has entered into a strategic partnership with Quintiles, to support Samsung’s entry into the bio pharmaceuticals market.

  • The New Health Alliance

    White Paper — January 10, 2011
    Biopharmaceutical companies must explore alternative strategic alliances that meet the needs of the New Health and produce medicines that demonstrate value to the entire constellation of stakeholders.

  • Adrian McKemey, Ph.D.

    Hear from the Experts — March 25, 2009
    Adrian leads the Product Development and Commercialization consulting practice at Quintiles Global Consulting.

Page 1 of 1 (5 results)

Subscribe to Email Based on Your Interests

Set preferences